CD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: A novel subset of inducible human regulatory T cells

Journal of Immunology

Volumn 189, Issue 5, 2012, Pages 2118-2130

  Suzuki, Masakatsu ^a,b   Jagger, Ann L ^a   Konya, Christine ^a,c   Shimojima, Yasuhiro ^a   Pryshchep, Sergey ^a,d   Goronzy, Jörg J ^a   Weyand, Cornelia M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DAIICHI SANKYO CO   (Japan)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CALCIUM; CD27 ANTIGEN; CD28 ANTIGEN; CD3 ANTIBODY; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; INTERLEUKIN 15; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROTEIN KINASE ZAP 70; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGE; AGED; ANTIGEN EXPRESSION; ARTICLE; CALCIUM CELL LEVEL; CD4+ T LYMPHOCYTE; CD8+ CD45RA+ CCR7+ FOXP3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MEMORY CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIGENS, CD45; ANTIGENS, CD8; CELL DEATH; CELL DIFFERENTIATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; MIDDLE AGED; PRIMARY CELL CULTURE; RECEPTORS, CCR7; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84865418657     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200122     Document Type: Article

References (69)

1. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787.
2. Belkaid, Y., and K. Tarbell. 2009. Regulatory T cells in the control of host-microorganism interactions (*). Annu. Rev. Immunol. 27: 551-589.
3. Zheng, Y., and A. Y. Rudensky. 2007. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8: 457-462.
4. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24: 209-226.
5. Wang, J., A. Ioan-Facsinay, E. I. van der Voort, T. W. Huizinga, and R. E. Toes. 2007. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur. J. Immunol. 37: 129-138.
6. Lio, C. W., and C. S. Hsieh. 2008. A two-step process for thymic regulatory T cell development. Immunity 28: 100-111.
7. Hsieh, C. S., Y. Zheng, Y. Liang, J. D. Fontenot, and A. Y. Rudensky. 2006. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat. Immunol. 7: 401-410.
8. Zheng, S. G., J. H. Wang, W. Stohl, K. S. Kim, J. D. Gray, and D. A. Horwitz. 2006. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J. Immunol. 176: 3321-3329.
9. Apostolou, I., and H. von Boehmer. 2004. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199: 1401-1408.
10. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6: 1219-1227.
11. Fantini, M. C., C. Becker, G. Monteleone, F. Pallone, P. R. Galle, and M. F. Neurath. 2004. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172: 5149-5153.
12. Curotto de Lafaille, M. A., A. C. Lino, N. Kutchukhidze, and J. J. Lafaille. 2004. CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J. Immunol. 173: 7259-7268.
13. Mucida, D., N. Kutchukhidze, A. Erazo, M. Russo, J. J. Lafaille, and M. A. Curotto de Lafaille. 2005. Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115: 1923-1933.
14. Zheng, S. G., J. H. Wang, J. D. Gray, H. Soucier, and D. A. Horwitz. 2004. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J. Immunol. 172: 5213-5221.
15. Hori, S. 2010. Developmental plasticity of Foxp3+ regulatory T cells. Curr. Opin. Immunol. 22: 575-582.
16. Horwitz, D. A., S. G. Zheng, and J. D. Gray. 2008. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol. 29: 429-435.
17. Feuerer, M., J. A. Hill, K. Kretschmer, H. von Boehmer, D. Mathis, and C. Benoist. 2010. Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc. Natl. Acad. Sci. USA 107: 5919-5924.
18. Vignali, D. A., L. W. Collison, and C. J. Workman. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
19. Shevach, E. M. 2009. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645.
20. Yamaguchi, T., J. B. Wing, and S. Sakaguchi. 2011. Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or noninflammatory conditions. Semin. Immunol. 23: 424-430.
21. Ernst, P. B., J. C. Garrison, and L. F. Thompson. 2010. Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology. J. Immunol. 185: 1993-1998.
22. Joosten, S. A., K. E. van Meijgaarden, N. D. Savage, T. de Boer, F. Triebel, A. van der Wal, E. de Heer, M. R. Klein, A. Geluk, and T. H. Ottenhoff. 2007. Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc. Natl. Acad. Sci. USA 104: 8029-8034.
23. Sakaguchi, S., K. Wing, Y. Onishi, P. Prieto-Martin, and T. Yamaguchi. 2009. Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21: 1105-1111.
24. Kapp, J. A. 2008. Special regulatory T-cell review: suppressors regulated but unsuppressed. Immunology 123: 28-32.
25. Ottenhoff, T. H., D. G. Elferink, P. R. Klatser, and R. R. de Vries. 1986. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Nature 322: 462-464.
26. Modlin, R. L., H. Kato, V. Mehra, E. E. Nelson, X. D. Fan, T. H. Rea, P. K. Pattengale, and B. R. Bloom. 1986. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Nature 322: 459-461.
27. Joosten, S. A., and T. H. Ottenhoff. 2008. Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination. Hum. Immunol. 69: 760-770.
28. Cosmi, L., F. Liotta, E. Lazzeri, M. Francalanci, R. Angeli, B. Mazzinghi, V. Santarlasci, R. Manetti, V. Vanini, P. Romagnani, et al. 2003. Human CD8+ CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 102: 4107-4114.
29. Uss, E., A. T. Rowshani, B. Hooibrink, N. M. Lardy, R. A. van Lier, and I. J. ten Berge. 2006. CD103 is a marker for alloantigen-induced regulatory CD8+ T cells. J. Immunol. 177: 2775-2783.
30. Colovai, A. I., M. Mirza, G. Vlad, S. Wang, E. Ho, R. Cortesini, and N. Suciu- Foca. 2003. Regulatory CD8+CD28- T cells in heart transplant recipients. Hum. Immunol. 64: 31-37.
31. Bisikirska, B., J. Colgan, J. Luban, J. A. Bluestone, and K. C. Herold. 2005. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J. Clin. Invest. 115: 2904-2913.
32. Jiang, H., S. M. Canfield, M. P. Gallagher, H. H. Jiang, Y. Jiang, Z. Zheng, and L. Chess. 2010. HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes. J. Clin. Invest. 120: 3641-3650.
33. Correale, J., and A. Villa. 2010. Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis. Ann. Neurol. 67: 625-638.
34. Chaput, N., S. Louafi, A. Bardier, F. Charlotte, J. C. Vaillant, F. Ménégaux, M. Rosenzwajg, F. Lemoine, D. Klatzmann, and J. Taieb. 2009. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Gut 58: 520-529.
35. Nigam, P., V. Velu, S. Kannanganat, L. Chennareddi, S. Kwa, M. Siddiqui, and R. R. Amara. 2010. Expansion of FOXP3+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control. J. Immunol. 184: 1690-1701.
36. Suzuki, M., C. Konya, J. J. Goronzy, and C. M. Weyand. 2008. Inhibitory CD8+ T cells in autoimmune disease. Hum. Immunol. 69: 781-789.
37. Pryshchep, S., J. J. Goronzy, S. Parashar, and C. M. Weyand. 2010. Insufficient deactivation of the protein tyrosine kinase lck amplifies T-cell responsiveness in acute coronary syndrome. Circ. Res. 106: 769-778.
38. Czesnikiewicz-Guzik, M., W. W. Lee, D. Cui, Y. Hiruma, D. L. Lamar, Z. Z. Yang, J. G. Ouslander, C. M. Weyand, and J. J. Goronzy. 2008. T cell subset-specific susceptibility to aging. Clin. Immunol. 127: 107-118.
39. Filaci, G., D. Fenoglio, and F. Indiveri. 2011. CD8(+) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity. Autoimmunity 44: 51-57.
40. Wilson, R. W., M. L. Chenggis, and E. R. Unger. 1990. Longitudinal study of human papillomavirus infection of the female urogenital tract by in situ hybridization. Arch. Pathol. Lab. Med. 114: 155-159.
41. Lu, L., and H. Cantor. 2008. Generation and regulation of CD8(+) regulatory T cells. Cell. Mol. Immunol. 5: 401-406.
42. Smith, T. R., and V. Kumar. 2008. Revival of CD8+ Treg-mediated suppression. Trends Immunol. 29: 337-342.
43. Vlad, G., C. C. Chang, A. I. Colovai, E. R. Vasilescu, R. Cortesini, and N. Suciu- Foca. 2010. Membrane and soluble ILT3 are critical to the generation of T suppressor cells and induction of immunological tolerance. Int. Rev. Immunol. 29: 119-132.
44. Konya, C., J. J. Goronzy, and C. M. Weyand. 2009. Treating autoimmune disease by targeting CD8(+) T suppressor cells. Expert Opin. Biol. Ther. 9: 951-965.
45. Kapp, J. A., and R. P. Bucy. 2008. CD8+ suppressor T cells resurrected. Hum. Immunol. 69: 715-720.
46. Skaggs, B. J., R. P. Singh, and B. H. Hahn. 2008. Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice. Hum. Immunol. 69: 790-796.
47. Sarantopoulos, S., L. Lu, and H. Cantor. 2004. Qa-1 restriction of CD8+ suppressor T cells. J. Clin. Invest. 114: 1218-1221.
48. Jiang, H., and L. Chess. 2004. An integrated view of suppressor T cell subsets in immunoregulation. J. Clin. Invest. 114: 1198-1208.
49. Jarvis, L. B., M. K. Matyszak, R. C. Duggleby, J. C. Goodall, F. C. Hall, and J. S. Gaston. 2005. Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function. Eur. J. Immunol. 35: 2896-2908.
50. Gattinoni, L., E. Lugli, Y. Ji, Z. Pos, C. M. Paulos, M. F. Quigley, J. R. Almeida, E. Gostick, Z. Yu, C. Carpenito, et al. 2011. A human memory T cell subset with stem cell-like properties. Nat. Med. 17: 1290-1297.
51. Aspinall, R., and J. J. Goronzy. 2010. Immune senescence. Curr. Opin. Immunol. 22: 497-499.
52. Buchholz, V. R., M. Neuenhahn, and D. H. Busch. 2011. CD8+ T cell differentiation in the aging immune system: until the last clone standing. Curr. Opin. Immunol. 23: 549-554.
53. Weng, N. P., A. N. Akbar, and J. Goronzy. 2009. CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol. 30: 306-312.
54. Mohan, S. V., Y. J. Liao, J. W. Kim, J. J. Goronzy, and C. M. Weyand. 2011. Giant cell arteritis: immune and vascular aging as disease risk factors. Arthritis Res. Ther. 13: 231.
55. Weyand, C. M., H. Fujii, L. Shao, and J. J. Goronzy. 2009. Rejuvenating the immune system in rheumatoid arthritis. Nat Rev Rheumatol 5: 583-588.
56. Shao, L., H. Fujii, I. Colmegna, H. Oishi, J. J. Goronzy, and C. M. Weyand. 2009. Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis. J. Exp. Med. 206: 1435-1449.
57. Fujii, H., L. Shao, I. Colmegna, J. J. Goronzy, and C. M. Weyand. 2009. Telomerase insufficiency in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 106: 4360-4365.
58. Naylor, K., G. Li, A. N. Vallejo, W. W. Lee, K. Koetz, E. Bryl, J. Witkowski, J. Fulbright, C. M. Weyand, and J. J. Goronzy. 2005. The influence of age on T cell generation and TCR diversity. J. Immunol. 174: 7446-7452.
59. Goronzy, J. J., J. W. Fulbright, C. S. Crowson, G. A. Poland, W. M. O'Fallon, and C. M.Weyand. 2001. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J. Virol. 75: 12182-12187.
60. Cheng, G., A. Yu, and T. R. Malek. 2011. T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol. Rev. 241: 63-76.
61. Vang, K. B., J. Yang, S. A. Mahmud, M. A. Burchill, A. L. Vegoe, and M. A. Farrar. 2008. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development. J. Immunol. 181: 3285-3290.
62. Kim, H. J., X. Wang, S. Radfar, T. J. Sproule, D. C. Roopenian, and H. Cantor. 2011. CD8+ T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice. Proc. Natl. Acad. Sci. USA 108: 2010-2015.
63. Andersen, M. H., R. B. Sørensen, M. K. Brimnes, I. M. Svane, J. C. Becker, and P. thor Straten. 2009. Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients. J. Clin. Invest. 119: 2245-2256.
64. Shi, Z., Y. Okuno, M. Rifa'i, A. T. Endharti, K. Akane, K. Isobe, and H. Suzuki. 2009. Human CD8+CXCR3+ T cells have the same function as murine CD8+ CD122+ Treg. Eur. J. Immunol. 39: 2106-2119.
65. Bhowmick, S., R. B. Clark, S. Brocke, and R. E. Cone. 2011. Antigen-specific splenic CD4+ and CD8+ regulatory T cells generated via the eye, suppress experimental autoimmune encephalomyelitis either at the priming or at the effector phase. Int. Immunol. 23: 119-128.
66. Sakaguchi, S. 2011. Regulatory T cells: history and perspective. Methods Mol. Biol. 707: 3-17.
67. Takemura, S., A. Braun, C. Crowson, P. J. Kurtin, R. H. Cofield, W. M. O'Fallon, J. J. Goronzy, and C. M. Weyand. 2001. Lymphoid neogenesis in rheumatoid synovitis. J. Immunol. 167: 1072-1080.
68. Seyler, T. M., Y. W. Park, S. Takemura, R. J. Bram, P. J. Kurtin, J. J. Goronzy, and C. M. Weyand. 2005. BLyS and APRIL in rheumatoid arthritis. J. Clin. Invest. 115: 3083-3092.
69. Klimiuk, P. A., J. J. Goronzy, and C. M. Weyand. 1999. IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis. J. Immunol. 162: 4293-4299.